English | Español

Biospace
Patient Daily | Jan 14, 2026

Calls grow for stronger federal action as US risks losing edge in biotechnology
Patient Daily | Jan 13, 2026

Biotech investors predict active dealmaking and broader focus for 2026
Patient Daily | Jan 13, 2026

Analysts anticipate rebound for biopharma venture capital after late-2025 surge
Patient Daily | Jan 13, 2026

FDA rejects Vanda’s bid for Hetlioz approval in treating jet lag
Patient Daily | Jan 13, 2026

Eli Lilly acquires Ventyx Biosciences for $1.2B; announces cancer therapy pact with InduPro
Patient Daily | Jan 13, 2026

Parabilis secures $305M to advance cancer drug amid biotech fundraising surge
Patient Daily | Jan 13, 2026

J.P. Morgan Healthcare Conference spotlights obesity drugs and Q4 sales growth
Patient Daily | Jan 13, 2026

Novartis explains cautious approach toward GLP-1 drugs amid crowded market

Trending
Patient Daily | Mar 6, 2026

Dallas Breathe Free ranked top ENT practice in region by reviewers on Google
+ Pharmaceuticals
Patient Daily | Mar 9, 2026

Rep. Marshall on 340B expansion: 'If 340B is to continue growing, lawmakers should ensure it truly benefits the underserved'
+ Pharmaceuticals
Patient Daily | Mar 7, 2026

FDA prepares decisions on key drugs from BMS, GSK, Aldeyra and others
+ Pharmaceuticals
Patient Daily | Mar 7, 2026

Merck and Pfizer report positive phase 3 results for bladder cancer drug combination